• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植酸作为肾结石形成抑制剂的潜在热力学和动力学作用:理论建模与结晶实验。

Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

机构信息

1Department of Chemistry, University of Cape Town, Rondebosch, Private Bag, Cape Town, 7701, South Africa.

出版信息

Urolithiasis. 2019 Dec;47(6):493-502. doi: 10.1007/s00240-019-01117-1. Epub 2019 Feb 14.

DOI:10.1007/s00240-019-01117-1
PMID:30767040
Abstract

Kidney stone formation is governed by thermodynamic (supersaturation) and kinetic (crystal nucleation, growth, aggregation) mechanisms. We adopted a dual theoretical and experimental approach to investigate the potential role of urinary phytate in this regard. Thermodynamic constants for eight protonated phytate species and seven calcium-phytate complexes were determined by potentiometry and incorporated into the speciation program JESS. Urine was collected from 16 heathy males and their urine compositions were used as input for JESS. Phytate concentration was varied during modelling. No statistically significant decreases in Ca concentrations or in supersaturation values were predicted by JESS. Crystallization experiments were then performed in pooled urine. Endogenous phytate concentration was determined using a metal-dye assay. The pool was dosed with various concentrations of phytate to achieve final concentrations equivalent to those used for modelling. Experiments showed that phytate had no effects on Ca concentrations (as predicted by our theoretical modelling), metastable limits or crystal nucleation and growth kinetics. However, crystal aggregation kinetics was inhibited. We speculate that HPhy, small amounts of which were revealed by modelling, may bind to crystal surfaces and inhibit aggregation. We conclude that phytate exerts a kinetic, but not a thermodynamic inhibitory effect on crystallization in urine.

摘要

肾结石的形成受热力学(过饱和度)和动力学(晶体成核、生长、聚集)机制的控制。我们采用了理论和实验相结合的方法来研究尿植酸在这方面的潜在作用。通过电位滴定法确定了八种质子化植酸物种和七种钙-植酸络合物的热力学常数,并将其纳入了物种形成程序 JESS 中。从 16 名健康男性中收集尿液,并将其尿液成分用作 JESS 的输入。在建模过程中改变了植酸浓度。JESS 没有预测到 Ca 浓度或过饱和度值有统计学意义的降低。然后在混合尿液中进行了结晶实验。使用金属染料测定法测定内源性植酸浓度。向池内加入不同浓度的植酸,以达到与建模中使用的浓度相当的终浓度。实验表明,植酸对 Ca 浓度(如我们的理论建模所预测)、亚稳限或晶体成核和生长动力学没有影响。然而,晶体聚集动力学受到抑制。我们推测,建模中揭示的少量 HPhy 可能与晶体表面结合并抑制聚集。我们得出结论,植酸对尿液中的结晶具有动力学而非热力学抑制作用。

相似文献

1
Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.植酸作为肾结石形成抑制剂的潜在热力学和动力学作用:理论建模与结晶实验。
Urolithiasis. 2019 Dec;47(6):493-502. doi: 10.1007/s00240-019-01117-1. Epub 2019 Feb 14.
2
Phytate acts as an inhibitor in formation of renal calculi.植酸盐在肾结石形成过程中起抑制剂作用。
Front Biosci. 2007 Jan 1;12:2580-7. doi: 10.2741/2256.
3
Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.草酸钙结石患者与健康人群的尿植酸盐——饮食对植酸盐排泄的影响
Scand J Urol Nephrol. 2000 Jun;34(3):162-4. doi: 10.1080/003655900750016526.
4
Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).尿石形成风险测试:在使用结晶抑制剂(柠檬酸盐和植酸盐)评估肾结石治疗中的作用。
Arch Esp Urol. 1999 Apr;52(3):305-10.
5
Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.肌醇六磷酸(植酸)对钙结合、草酸钙结晶及体外结石生长的影响。
J Urol. 2007 Jun;177(6):2366-70. doi: 10.1016/j.juro.2007.01.113.
6
Exploring the Potential Relationship Between Phytate Ingestion, Urinary Phytate Excretion, and Renal Stone Risk in a Unique Human Model: No Hard Evidence in Support of Phytate as a Stone Inhibitor.探讨在独特的人体模型中植酸盐摄入、尿植酸盐排泄与肾结石风险之间的潜在关系:没有确凿证据支持植酸盐作为结石抑制剂。
J Ren Nutr. 2020 Sep;30(5):396-403. doi: 10.1053/j.jrn.2019.10.006. Epub 2020 Jan 9.
7
Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).尿石症风险测试:在使用结晶抑制剂(柠檬酸盐和植酸盐)评估肾结石治疗中的作用。
Arch Esp Urol. 1999 Jan-Feb;52(1):94-9.
8
Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.“结晶抑制剂”在预防肾结石方面有作用吗?一种批评。
Urolithiasis. 2017 Feb;45(1):43-56. doi: 10.1007/s00240-016-0953-y. Epub 2016 Nov 29.
9
Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.镁、柠檬酸盐和植酸盐混合物作为尿液草酸钙结晶抑制剂的功效。
J Urol. 2015 Sep;194(3):812-9. doi: 10.1016/j.juro.2015.03.099. Epub 2015 Mar 26.
10
Role of urinary bikunin in the inhibition of calcium oxalate crystallization.尿抑肽在草酸钙结晶抑制中的作用。
J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S385-8.

引用本文的文献

1
Bio-inspired multifunctional disruptors of calcium oxalate crystallization.受生物启发的草酸钙结晶多功能干扰剂。
Nat Commun. 2025 Jun 5;16(1):5229. doi: 10.1038/s41467-025-60320-4.
2
Systematic review of pharmacological, complementary, and alternative therapies for the prevention of calcium oxalate stones.预防草酸钙结石的药物、补充和替代疗法的系统评价
Asian J Urol. 2025 Apr;12(2):169-188. doi: 10.1016/j.ajur.2024.04.006. Epub 2024 Jul 4.
3
The phytase RipBL1 enables the assignment of a specific inositol phosphate isomer as a structural component of human kidney stones.

本文引用的文献

1
Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis.食物中的植酸盐及其对人类的意义:食物来源、摄入量、加工、生物利用率、保护作用及分析
Mol Nutr Food Res. 2009 Sep;53 Suppl 2:S330-75. doi: 10.1002/mnfr.200900099.
2
GLEE, a new computer program for glass electrode calibration.GLEE,一种用于玻璃电极校准的新计算机程序。
Talanta. 2000 Jan 24;51(1):33-7. doi: 10.1016/s0039-9140(99)00245-3.
3
Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs.
植酸酶RipBL1能够确定一种特定的肌醇磷酸异构体作为人类肾结石的结构成分。
RSC Chem Biol. 2023 Jan 27;4(4):300-309. doi: 10.1039/d2cb00235c. eCollection 2023 Apr 5.
4
LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone.LITHORISK.COM:一款用于计算和可视化肾结石风险的软件的新版本。
Urolithiasis. 2021 Jun;49(3):211-217. doi: 10.1007/s00240-020-01228-0. Epub 2020 Nov 27.
5
Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.肌醇六磷酸(植酸)和病理性钙化的关键方面。
Molecules. 2019 Dec 4;24(24):4434. doi: 10.3390/molecules24244434.
溶液中平衡的研究。使用HYPERQUAD程序套件测定平衡常数。
Talanta. 1996 Oct;43(10):1739-53. doi: 10.1016/0039-9140(96)01958-3.
4
JESS, A joint expert speciation system-I. Raison d'être.JESS,一种联合专家物种形成系统-I。存在的理由。
Talanta. 1991 Dec;38(12):1409-17. doi: 10.1016/0039-9140(91)80289-c.
5
Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.凝血酶原片段1的糖基化作用控制草酸钙晶体的成核和聚集,但不影响晶体生长。
Urol Res. 2007 Dec;35(6):277-85. doi: 10.1007/s00240-007-0119-z. Epub 2007 Nov 7.
6
Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.肌醇六磷酸(植酸)对钙结合、草酸钙结晶及体外结石生长的影响。
J Urol. 2007 Jun;177(6):2366-70. doi: 10.1016/j.juro.2007.01.113.
7
Phytate acts as an inhibitor in formation of renal calculi.植酸盐在肾结石形成过程中起抑制剂作用。
Front Biosci. 2007 Jan 1;12:2580-7. doi: 10.2741/2256.
8
Speciation of phytate ion in aqueous solution. Sequestration of magnesium and calcium by phytate at different temperatures and ionic strengths, in NaCl(aq).水溶液中植酸根离子的形态。在不同温度和离子强度下,于NaCl水溶液中植酸对镁和钙的螯合作用。
Biophys Chem. 2006 Oct 20;124(1):18-26. doi: 10.1016/j.bpc.2006.05.027. Epub 2006 Jun 12.
9
In vitro calcium oxalate crystallisation methods.体外草酸钙结晶方法。
Urol Res. 2006 Apr;34(2):139-45. doi: 10.1007/s00240-005-0027-z. Epub 2006 Jan 14.
10
Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.柠檬酸钠制剂在草酸钙尿路结石管理中的预防和治疗特性:随机、安慰剂对照试验
Urol Res. 2005 May;33(2):116-24. doi: 10.1007/s00240-005-0466-6. Epub 2005 May 4.